Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Mar 2021 07:00

RNS Number : 9447T
Sopheon PLC
31 March 2021
 

SOPHEON PLC

("Sopheon" or the "Company")

 

Directorate Change

 

Gregory Coticchia appointed as Chief Executive Officer

 

Sopheon, an international global leader in enterprise innovation management solutions, is pleased to announce that Gregory Coticchia has today joined the Board in the role of Chief Executive Officer.

 

Since 12 October 2020 Greg, who is based in the USA, has served as President of Sopheon responsible for the day to day operations, with a focus on accelerating the Company's SaaS transition and to spearhead cloud development plans.

 

Prior to his appointment Greg worked as a consultant to the Company. Greg has deep experience in cloud software products and services, holding executive roles in several organizations ranging from start-ups to $1bn revenue businesses, where he has been responsible for driving both organic and acquisition-led growth. This includes stints serving as CEO, President or COO, as well as marketing leadership roles. He has launched several new companies, either as lead entrepreneur or through incubation. Alongside his leadership and business credentials, he has been involved or responsible for the launch of over 100 products and solutions and is a recognized authority within the fields of product management and product development. Underlining his achievements, prior to joining Sopheon, Greg was asked to establish the Master's Program in Product Management at Carnegie Mellon University, and then served as the executive director of the program while continuing to provide business coaching and consulting to a variety of corporate organizations.

Greg Coticchia commented: "Digital transformation continues to accelerate, and innovation is an urgent imperative for virtually every company. Sopheon has a large opportunity to build off the very impressive client base and grow through the expansion of new cloud solutions. I am both honoured and excited to lead Sopheon in this next phase of growth."

As part of this planned transition strategy, Andy Michuda has become Executive Chairman of Sopheon's Board of Directors. Andy will focus on partnerships and acquisitions, in addition to his governance responsibilities. Barry Mence, who has been Chairman of the Board since the Company's inception, will serve as a non-executive director of Sopheon and remain a major shareholder in the Company.

Andy Michuda commented: "On behalf of the Sopheon Board, I would like to officially give a warm welcome to Greg as our new Chief Executive Officer. Greg's experience and track record in software and innovation are invaluable. He has already had a significant impact on the business in his short tenure as President. With Greg as our Chief Executive, I believe we are well placed to continue to deliver our SaaS transition, and to access a number of major growth opportunities in the future. I look forward to working alongside Greg to deliver value for Sopheon shareholders over the coming years."

The following information regarding the appointment of Gregory Michael Coticchia (aged 60) is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies.

As at the date of this announcement Greg holds no ordinary shares in the Company and 20,000 options over ordinary shares.

Current Directorships or Partnerships

Previous Directorships or Partnerships held in the past 5 years

ENTRA, Incorporated

PGHPCamp

Axiom Advancement Corp.

None

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

 

For further information contact:

Andy Michuda, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (Corporate Finance)Alice Lane / Sunila de Silva (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

About Sopheon.  Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXDEDSKFEEA
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.